Previous studies showed a close association between Mcl-1 dysfunction and colorectal cancer; Mcl-1 ubiquitin degradation was considered as a key target of reversing the resistance of colorectal cancer [15, 16]. The gene discussed is MCL1; the disease is colorectal cancer.